New Advances in Brain & Critical Care(NABCC)
ISSN: 2771-7887 | DOI: 10.33140/NABCC
Impact Factor: 1.01
Researchers and authors can directly submit their manuscript online through this link Online Manuscript Submission.
Anti-Amyloid-B Monoclonal Antibodies against Alzheimers Disease may be a Poten-tial Breakthrough for Cataract Treatment
Abstract
Ali Rahmani
The opacification of the lens, called cataracts, is responsible for degrading visual acuity as a consequence of scattering the light as it passes through the lens. The ocular lens plays a pivotal part in focusing the light onto the retina, and its clarity is essential for visual acuity. In 2020, the prevalence of cataracts had been 15.2 million cases among over 50 years globally. It has been estimated by the year 2050, approximately 50 million people in the united states will suffer from cataracts. According to statistics, cataracts will increase with passing years.